期刊文献+

心房颤动患者心房组织血管紧张素Ⅱ受体表达的研究 被引量:23

Regulation of atrial angiotensin Ⅱ receptor subtypes in human atrial fibrillation
原文传递
导出
摘要 目的 探讨心房颤动 (房颤 )患者心房组织血管紧张素Ⅱ受体 (AT R)基因转录和蛋白质表达的变化。方法  33例风湿性心脏瓣膜病患者 ,心脏外科手术时取右心耳组织。通过逆转录 聚合酶链反应和免疫组织化学 ,测量血管紧张素Ⅱ受体 1(AT1 R)和血管紧张素Ⅱ受体 2 (AT2 R)的mRNA和蛋白的相对表达量。结果 窦性心律患者、阵发性房颤及慢性房颤患者之间的心房组织AT1 R和AT2 R的mRNA水平差别均无显著性 (P均 >0 0 5 ) ;AT1 R和AT2 R在各组患者心房组织中主要表达在心房肌细胞 ;与窦性心律患者相比 ,阵发性房颤和慢性房颤患者的心房组织AT1 R的蛋白表达均明显减少 (P <0 0 5 ;P <0 0 1) ,而AT2 R的蛋白表达均明显增高 (P <0 0 1;P <0 0 5 )。结论 心房在房颤时AT1 R表达下调而AT2 R表达上调 。 Objective To determine the atrial expression of angiotensin Ⅱ type 1 and type 2 receptors(AT 1 R and AT 2 R)in human atrial fibrillation(AF).Methods A total of 33 patients with rheumatic heart disease were included.Atrial tissue was obtained from the right atrial appendage during open heart surgery.AT 1 R and AT 2 R were semi quantified at the mRNA and protein level by reverse transcription polymerase chain reaction and immunohistochemistry.Results AT 1 R or AT 2 R mRNA content was similar in all three groups ( P all>0 05).Both types of AT R were predominantly expressed in atrial myocytes in all three groups.The proteins of AT 1 R in patients with paroxysmal AF and chronic AF were significantly decreased compared with patients in sinus rhythm(0 257±0 074 vs 0 345±0 041, P <0 05;0 213±0 053 vs 0 345±0 041, P <0 01). In contrast,AT 2 R in patients with paroxysmal AF and chronic AF significantly increased(0 288±0 069 vs 0 183±0 043, P <0 01;0 236±0 065 vs 0 183±0 043, P <0 05).Conclusions AF is associated with the down regulation of atrial AT 1 R and the up regulation of AT 2 R proteins.These findings may help define the pathophysiological role of the angiotensin system in the structural remodeling of the fibrillating atria.
出处 《中华心律失常学杂志》 2002年第4期211-214,共4页 Chinese Journal of Cardiac Arrhythmias
关键词 心房颤动 心房组织 血管紧张素Ⅱ受体 聚合酶链反应 心房结构重构 免疫组织化学 Atrial fibrillation Angiotensin Ⅱ receptor Polymerase chain reaction
  • 相关文献

参考文献7

  • 1Van den Berg MP,Crijns HJGM, Van veldhuisen DJ,et al.Effects of lisinopril in patient with heart failure and chronic atrial fibrillation. J Card Failure, 1995,1: 355-363.
  • 2Pedersen OD,Bagger H,Kober L,et al. Trandolapril reduces the incidence of atrial fibrillation after acure myocardial infarction in patients with left ventricular dysfunction. Circulation, 1999,100: 376-380.
  • 3Goette A, Staack T, Rocken C, et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol,2000,35: 1669-1677.
  • 4Rogg H,de Gasparo M,Graedel E,et al. Angiotensin Ⅱ-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction. Eur Heart J, 1996,17:1112-1120.
  • 5Asano K, Dutcher DL, Port JD, et al. Selective downregulation of the angiotensin Ⅱ AT1-receptor subtype in failing human ventricular myocardium. Circulation, 1997,95: 11931200.
  • 6Matsubara H. Pathophysiological role of angiotensin Ⅱ type 2 receptor in cardiovascular and renal diseases. Circ Res,1998,83:1182-1191.
  • 7Goette A,Amdt M,Rocken C,et al. Regulation of angiotension Ⅱ receptor subtypes during atrial fibrillation in humans. Circulation, 2000,101: 2678-2781.

同被引文献175

引证文献23

二级引证文献377

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部